Crystal form of quinoxaline-2-carboxylic acid 4-carbamoyl-1- (3-fluorobenzyl) -2,7-dihydroxy-7-methyl-octyl -amide

摘要

This invention relates to crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide, useful in treating or preventing a disorder or condition by antagonizing the CCR1 receptor, and to their methods of preparation and use.